Rochaix P - Search Results

1

Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.

Peron JM, Couderc B, Rochaix P, Douin-Echinard V, Asnacios A, Souque A, Voigt JJ, Buscail L, Vinel JP, Favre G. Peron JM, et al. Among authors: rochaix p. J Gastroenterol Hepatol. 2004 Apr;19(4):388-96. doi: 10.1111/j.1440-1746.2003.03295.x. J Gastroenterol Hepatol. 2004. PMID: 15012775

2

The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.

Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B. Douin-Echinard V, et al. Among authors: rochaix p. Cancer Gene Ther. 2000 Dec;7(12):1543-56. doi: 10.1038/sj.cgt.7700268. Cancer Gene Ther. 2000. PMID: 11228533

3

Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.

Douin V, Bornes S, Creancier L, Rochaix P, Favre G, Prats AC, Couderc B. Douin V, et al. Among authors: rochaix p. BMC Biotechnol. 2004 Jul 27;4:16. doi: 10.1186/1472-6750-4-16. BMC Biotechnol. 2004. PMID: 15279677 Free PMC article.

4

Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.

Asnacios A, Courbon F, Rochaix P, Bauvin E, Cances-Lauwers V, Susini C, Schulz S, Boneu A, Guimbaud R, Buscail L. Asnacios A, et al. Among authors: rochaix p. J Clin Oncol. 2008 Feb 20;26(6):963-70. doi: 10.1200/JCO.2007.12.7431. J Clin Oncol. 2008. PMID: 18281671

5

Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells.

Sarrabayrouse G, Pich C, Moriez R, Armand-Labit V, Rochaix P, Favre G, Tilkin-Mariamé AF. Sarrabayrouse G, et al. Among authors: rochaix p. PLoS One. 2010 Feb 3;5(2):e9043. doi: 10.1371/journal.pone.0009043. PLoS One. 2010. PMID: 20140259 Free PMC article.

6

Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.

Rochaix P, Delesque N, Estève JP, Saint-Laurent N, Voight JJ, Vaysse N, Susini C, Buscail L. Rochaix P, et al. Hum Gene Ther. 1999 Apr 10;10(6):995-1008. doi: 10.1089/10430349950018391. Hum Gene Ther. 1999. PMID: 10223733

7

Statins Reduce Melanoma Development and Metastasis through MICA Overexpression.

Pich C, Teiti I, Rochaix P, Mariamé B, Couderc B, Favre G, Tilkin-Mariamé AF. Pich C, et al. Among authors: rochaix p. Front Immunol. 2013 Mar 13;4:62. doi: 10.3389/fimmu.2013.00062. eCollection 2013. Front Immunol. 2013. PMID: 23493799 Free PMC article.

8

PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.

Rochaix P, Lacroix-Triki M, Lamant L, Pichereaux C, Valmary S, Puente E, Al Saati T, Monsarrat B, Susini C, Buscail L, Delsol G, Voigt JJ. Rochaix P, et al. Mod Pathol. 2003 May;16(5):481-90. doi: 10.1097/01.MP.0000067686.34489.50. Mod Pathol. 2003. PMID: 12748255

9

The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.

Delmas C, End D, Rochaix P, Favre G, Toulas C, Cohen-Jonathan E. Delmas C, et al. Among authors: rochaix p. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6062-8. Clin Cancer Res. 2003. PMID: 14676133

10

Ex vivo discrimination between normal and pathological tissues in human breast surgical biopsies using bioimpedance spectroscopy.

Chauveau N, Hamzaoui L, Rochaix P, Rigaud B, Voigt JJ, Morucci JP. Chauveau N, et al. Among authors: rochaix p. Ann N Y Acad Sci. 1999 Apr 20;873:42-50. doi: 10.1111/j.1749-6632.1999.tb09447.x. Ann N Y Acad Sci. 1999. PMID: 10372148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters